---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-25-000076"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2025-07-28T23:59:59+00:00"
generated_at: "2026-05-18T00:16:43.895490+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nasdaq Hearings Panel grants SLRX additional extension to regain listing compliance by August 2025

## Summary
- Equity Standard compliance deadline extended to mid-August 2025 from late July.
- Minimum Bid Price compliance deadline extended to late August 2025 from early August.
- Company previously effected a reverse stock split within past year, affecting eligibility for standard compliance periods.
- Failure to meet milestones could result in delisting from Nasdaq.
- Company's common stock (SLRX) remains listed pending hearing process resolution.

## SEC filing metadata
- accession: 0001615219-25-000076
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2025-07-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000076/0001615219-25-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000076/flks-20250728.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-25-000076
- JSON: https://secwatch.observer/filing/0001615219-25-000076.json
- Plain text: https://secwatch.observer/filing/0001615219-25-000076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.